drugset / Trial / NCT04180943
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.
Timeline
- Start
- 2019-12-13
- Primary completion
- 2021-03-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Lidocaine | Other / unclassified | 2 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.5 % | Other |
| Comparator | Dexamethasone | Small molecule | — | Other |
Indications
No indication recorded.